You are here

Disc Medicine

Disc Medicine secures $200m financing to support trials

Clinical Trials Arena

Mon, 11/11/24 - 11:30 am

clinical trials

Disc maps out US filing for porphyria drug bitopertin

Pharmaphorum

Tue, 11/5/24 - 10:00 am

Disc Medicine Plummets After Placebo Effect Confounds Sunlight Sensitivity Study

Investors Business Daily

Mon, 04/1/24 - 11:24 pm

erythropoietic protoporphyria

FDA grants orphan drug designation for Disc’s PV treatment

Pharmaceutical Business Review

Mon, 02/12/24 - 11:45 am

polycythemia vera

Major readouts on the horizon for small developers

EP Vantage

Fri, 03/31/23 - 10:19 am

Aldeyra Therapeutics

Autolus Therapeutics

Bavarian Nordic

BioXcel Therapeutics

Editas Medicine

Mersana Therapeutics

NGM Biopharmaceuticals

Sutro BioPharma

Viking Therapeutics

Disc Medicine nabs $90M for blood disease pipeline, new Roche asset

Fierce Biotech

Thu, 09/2/21 - 09:34 am

venture capital

Disc Medicine nabs cash, big backers and biopharma drug deal

Fierce Biotech

Tue, 10/29/19 - 09:55 am

monoclonal antibodies